Mary Younji Sohn, MD in Rochester, MN - Medicare Pediatrics

Mary Younji Sohn, MD is a medicare enrolled "Pediatrics" physician in Rochester, Minnesota. Her current practice location is 200 1st St Sw, Rochester, Minnesota. You can reach out to her office (for appointments etc.) via phone at (507) 284-2511.

Mary Younji Sohn is licensed to practice in Minnesota (license number 33381) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1033730502.

Contact Information

	Mary Younji Sohn, MD
	200 1st St Sw, Rochester, MN 55905-0001
	(507) 284-2511
	Not Available

Physician's Profile

Full Name	Mary Younji Sohn
Gender	Female
Speciality	Pediatrics
Location	200 1st St Sw, Rochester, Minnesota
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1033730502
Provider Enumeration Date: 05/06/2020
Last Update Date: 10/26/2023

Medicare PECOS Information:

PECOS PAC ID: 2668839960
Enrollment ID: I20230601000227

Medical Identifiers

Medical identifiers for Mary Younji Sohn such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033730502	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	33381 (Minnesota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mary Younji Sohn is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mary Younji Sohn, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511	Mary Younji Sohn, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511

News Archive

Neuronal energy deficits may contribute to amyotrophic lateral sclerosis

Turning off a protein that helps cells balance energy increases animal mobility and reduces the death of nerve cells that control movement in animal models of amyotrophic lateral sclerosis (ALS), according to a study in the January 18 issue of The Journal of Neuroscience. The findings may one day guide new directions for the treatment of the progressive neurodegenerative disorder, for which there is currently no cure.

Astex and MMRC commence Phase II clinical trial of AT7519 CDK inhibitor in multiple myeloma

Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, and the Multiple Myeloma Research Consortium announced today the initiation of a Phase II clinical trial of the cyclin-dependent kinase inhibitor, AT7519, to treat patients with relapsed or refractory multiple myeloma, an incurable blood cancer. The trial is designed to investigate both single agent and combination activity of AT7519 with bortezomib (Velcade®).

New combination appears to be effective against cancer stem cells in pancreatic cancer

The new cancer medication sorafenib looks promising. Sorafenib is used for advanced liver and kidney cancer and also appears to be effective against cancer stem cells in pancreatic cancer. The team led by Professor Dr. Ingrid Herr, Head of the Department of Molecular Oncosurgery, a group of the Department of Surgery at Heidelberg University Hospital, (Managing Director: Professor Dr. Markus W. B-chler) in cooperation with the German Cancer Research Center, tested the new substance in mice and pancreatic cancer cells.

NeuroDerm starts patient enrollment in long-term safety study of ND0612 for treatment of Parkinson's disease

NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system disorders, today announced the start of patient enrollment in a long-term safety study (trial 012) of the company's continuously administered subcutaneous levodopa/carbidopa formulation used in both ND0612H and ND0612L.

Pediatrics Doctors in Rochester, MN

Alejandra Catalina Vasquez Avila, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511
Patricia S Simmons, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511
Mrs. Asmaa Ferdjallah, MD, MPH Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511
Dr. Mats Steffi Jennifer Masilamani, MD Pediatrics Medicare: May Accept Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511
Valeria Cristiani, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511
Flora Robinson Howie, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511
Meredith Mary Renda, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511

Mary Younji Sohn, MD - Medicare Pediatrics in Rochester, MN